Stocks / AXON vs SIDU

Axovant Sciences Ltd. Common Shares (AXON) vs Sidus Space, Inc. (SIDU)

Axovant Sciences Ltd. Common Shares and Sidus Space, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.

AXON is the larger company ($51.0B vs $0.4B). On the fundamentals, AXON grows revenue faster (32.5% vs 13.4%); AXON earns a higher net margin (4.5% vs -871.0%); AXON has the stronger return on equity (3.8% vs -58.2%). On the filings, SIDU carries fewer potential red flags (2 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AXON vs SIDU, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 Axovant Sciences Ltd. Common Shares (AXON)Sidus Space, Inc. (SIDU)
Market cap$51.0B$0.4B
Revenue (latest FY)$2.78B$3.38M
Net income (latest FY)$124.66M$-29.47M
Revenue growth (5y CAGR)32.5%13.4%
Net margin4.5%-871.0%
Return on equity3.8%-58.2%
P/E ratio262.7
Dividend yield
Profitable years (of last 10)80
Positive free cash flowYesNo

Performance — AXON vs SIDU

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 Axovant Sciences Ltd. Common Shares (AXON)Sidus Space, Inc. (SIDU)
1-year return-19.6%153.8%
3-year return182.2%-75.7%
5-year return230.3%
10-year return2118.4%
52-week range$339.01–$792.16$0.63–$6.79

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AXON vs SIDU breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AXON's full financials →   Open SIDU's full financials →

More comparisons

Frequently asked questions

Which is bigger, AXON or SIDU?

Axovant Sciences Ltd. Common Shares is larger by market capitalization — $51.0B versus $0.4B.

Which grows faster, AXON or SIDU?

Over the last five fiscal years, Axovant Sciences Ltd. Common Shares grew revenue faster — 32.5%/yr versus 13.4%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AXON fundamentals → · SIDU fundamentals → · All 1,500+ companies → · Free screener →